164 related articles for article (PubMed ID: 22360645)
1. Phosphate removal model: an observational study of low-flux dialyzers in conventional hemodialysis therapy.
Wang M; Li H; Liao H; Yu Y; You L; Zhu J; Huang B; Yuan L; Hao C; Chen J
Hemodial Int; 2012 Jul; 16(3):363-76. PubMed ID: 22360645
[TBL] [Abstract][Full Text] [Related]
2. Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients.
Tonelli M; Wang W; Hemmelgarn B; Lloyd A; Manns B;
Am J Kidney Dis; 2009 Dec; 54(6):1108-15. PubMed ID: 19619920
[TBL] [Abstract][Full Text] [Related]
3. Phosphate mass removal during hemodialysis: a comparison between eKT/V-matched conventional and extended dialysis.
Sampaio MS; Ruzany F; Dorigo DM; Suassuna JH
Am J Nephrol; 2012; 36(2):121-6. PubMed ID: 22776782
[TBL] [Abstract][Full Text] [Related]
4. [Factors which influence phosphorus removal in hemodialysis].
Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
[TBL] [Abstract][Full Text] [Related]
5. Impact of convective flow on phosphorus removal in maintenance hemodialysis patients.
Lornoy W; De Meester J; Becaus I; Billiouw JM; Van Malderen PA; Van Pottelberge M
J Ren Nutr; 2006 Jan; 16(1):47-53. PubMed ID: 16414441
[TBL] [Abstract][Full Text] [Related]
6. Calcium exposure and removal in chronic hemodialysis patients.
Sigrist M; McIntyre CW
J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440
[TBL] [Abstract][Full Text] [Related]
7. Impact of using two dialyzers in parallel on phosphate clearance in hemodialysis patients: a randomized trial.
Thompson S; Manns B; Lloyd A; Hemmelgarn B; MacRae J; Klarenbach S; Unsworth L; Courtney M; Tonelli M
Nephrol Dial Transplant; 2017 May; 32(5):855-861. PubMed ID: 27190374
[TBL] [Abstract][Full Text] [Related]
8. Modification and Validation of the Phosphate Removal Model: A Multicenter Study.
Zhang W; Du Q; Xiao J; Bi Z; Yu C; Ye Z; Wang M; Chen J
Kidney Blood Press Res; 2021; 46(1):53-62. PubMed ID: 33477164
[TBL] [Abstract][Full Text] [Related]
9. Association between phosphate removal and markers of bone turnover in haemodialysis patients.
Albalate M; de la Piedra C; Fernández C; Lefort M; Santana H; Hernando P; Hernández J; Caramelo C
Nephrol Dial Transplant; 2006 Jun; 21(6):1626-32. PubMed ID: 16490746
[TBL] [Abstract][Full Text] [Related]
10. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis.
Kuhlmann MK
Blood Purif; 2010; 29(2):137-44. PubMed ID: 20093819
[TBL] [Abstract][Full Text] [Related]
11. Short-term effects of online hemodiafiltration on phosphate control: a result from the randomized controlled Convective Transport Study (CONTRAST).
Penne EL; van der Weerd NC; van den Dorpel MA; Grooteman MP; Lévesque R; Nubé MJ; Bots ML; Blankestijn PJ; ter Wee PM;
Am J Kidney Dis; 2010 Jan; 55(1):77-87. PubMed ID: 19962805
[TBL] [Abstract][Full Text] [Related]
12. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
Zehnder C; Gutzwiller JP; Renggli K
Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
[TBL] [Abstract][Full Text] [Related]
13. Aerobic exercise increases phosphate removal during hemodialysis: a controlled trial.
Orcy R; Antunes MF; Schiller T; Seus T; Böhlke M
Hemodial Int; 2014 Apr; 18(2):450-8. PubMed ID: 24438516
[TBL] [Abstract][Full Text] [Related]
14. [Phosphate kinetics in patients on chronic hemodialysis].
Okuda N; Kuno T; Nagura Y; Kanmatsuse K
Nihon Jinzo Gakkai Shi; 2000 Jan; 42(1):30-5. PubMed ID: 10737011
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the hemodialysis adequacy conducted based on low-flux polysulfone dialyzers and high-flux helixone dialyzers].
Sobaszek-Pitas M; Kopeć J; Krzanowski M; Sułowicz W
Przegl Lek; 2014; 71(7):384-8. PubMed ID: 25338334
[TBL] [Abstract][Full Text] [Related]
16. Patient-specific phosphorus mobilization clearance during nocturnal and short daily hemodialysis.
Agar BU; Troidle L; Finkelstein FO; Kohn OF; Akonur A; Leypoldt JK
Hemodial Int; 2012 Oct; 16(4):491-6. PubMed ID: 22574966
[TBL] [Abstract][Full Text] [Related]
17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
18. Estimating phosphate removal in haemodialysis: an additional tool to quantify dialysis dose.
Gutzwiller JP; Schneditz D; Huber AR; Schindler C; Gutzwiller F; Zehnder CE
Nephrol Dial Transplant; 2002 Jun; 17(6):1037-44. PubMed ID: 12032194
[TBL] [Abstract][Full Text] [Related]
19. Inorganic phosphorus homeostasis during the first hour of dialysis.
Katopodis KP; Dounousi EC; Challa AS; Vlachou IA; Karasavvidou DP
Ren Fail; 2011; 33(6):562-7. PubMed ID: 21663386
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of phosphorus during hemodialysis and the calculation of its effective dialysis clearance.
Schück O; Kaslikov J
Clin Nephrol; 1997 Jun; 47(6):379-83. PubMed ID: 9202868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
